Behbahani Ali bought CRSP
August 6, 2025 · Form 4 insider transaction
Behbahani Ali bought 15 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 411 days after the transaction.
Footnotes
The Ali Behbahani Revocable Trust Dated June 26, 2015 (the "Behbahani Trust") received 15 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.; The Reporting Person is the trustee of the Behbahani Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the Common Shares of the Issuer held by the Behbahani Trust in which the Reporting Person has no pecuniary interest.